Atrial Fibrillation Trial, Recruiting NCT06315192 Sponsor: Region Skane Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06315192
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 50 years of age or older
  • You are mostly independent in daily life with little to no disability (confirm with trial site)
  • You have recently (within the last 2 weeks) had a mini-stroke (TIA) AND either have a high risk score, an irregular heart rhythm called atrial fibrillation, or significant narrowing/hardening of major arteries
  • You have recently (within the last 2 weeks) had an ischemic stroke (caused by a blockage) AND either have atrial fibrillation or significant narrowing/hardening of major arteries
  • You have an irregular heart rhythm (atrial fibrillation or flutter) AND are either not taking blood thinners or taking a reduced dose, AND have a high risk score for stroke (confirm with trial site)
  • You have recently (within the last 2 weeks) had a bleeding stroke in the brain AND have atrial fibrillation
  • You have agreed in writing to take part after being fully informed about the study
  • You have been a smartphone user for at least one year

Who may not be able to join:

  • You have already taken part in this study before
  • You have weakness or reduced movement in your arm due to any previous medical condition
  • You are not able to give your own consent to join the study
  • You do not speak or read any of the languages available in the study's smartphone app
  • You do not have access to a smartphone that works with the study's app
  • You have other health conditions or circumstances that would make it too difficult to use the app or attend follow-up appointments
  • You do not wish to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ulrika Anderson, Ms., Lund University

Phone: 800-555-5555

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Region Skane
Registry
ClinicalTrials.gov
Start date
5 September 2024
Est. completion
31 October 2027

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Alarm from device within 3 hours of onset of stroke with unilateral arm motor deficit.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov